Indication - Neglected tropical diseases
Trypanosoma cruzi IgG antibody
Facility level:
Assay formats
Status history
First added in 2020
Purpose type
Surveillance, Screening, Diagnosis, Monitoring
For surveillance of T. cruzi infection; To screen girls, women of childbearing age and pregnant women without previous treatment for T. cruzi infection; To screen children and other at-risk populations; To diagnose chronic T. cruzi infection (Chagas disease); To monitor treatment of T. cruzi infection
Specimen types
Serum, Plasma
WHO prequalified or recommended products
WHO supporting documents
Guidelines for the diagnosis and treatment of Chagas disease (2019) https://iris.paho.org/handle/10665.2/49653
ICD11 code: 1F9Z

Summary of SAGE IVD recommendation

General In vitro diagnostics tests are the general core and routine laboratory tests for clinical chemistry, haematology, blood transfusion, microbiology (virology, bacteriology, parasitology and mycology) and histopathology. These tests were selected on the basis of the scientific validity of an analyte, i.e. the association between an analyte and a clinical condition or physiological state; and clinical utility. Many of these tests are required for effective management of patients and have already been described in WHO publications.

Details of submission from 2020

The inclusion of this entry was based on WHO guidelines and technical reports that include recommendations for the appropriate IVDs.